Rite Aid Corporation (NYSE:RAD)
-- USD
0.000 0.000%Sponsored Reports
| Previous Close (in USD) | -- |
|---|---|
| Change | 0.000 0.000% |
| 52 W H/L (in USD) | 4.180/0.115 |
| EBITDA (in USD) | 282.871M |
| PE Ratio | -- |
| Volume | -- |
| Diluted Eps TTM | -14.34 |
| Total Assets (in USD) | 7527.362M |
|---|---|
| Total Liabilities (in USD) | 8169.138M |
| Revenue TTM (in USD) | 23730.477M |
| Cash (in USD) | 157.151M |
| Market Cap (in USD) | 36.756 M |
| Revenue Per Share TTM | 432.346 |
| Gross Profit TTM (in USD) | 4803.94M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Rite Aid Corporation
Employees: 47000
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Ms. Heyward Rutledge Donigan B.A. | Pres, CEO & Director | 1961 |
| 2. | Mr. Matthew C. Schroeder | CFO & Exec. VP | 1970 |
| 3. | Mr. Paul D. Gilbert | Exec. VP, Gen. Counsel & Corp. Sec. | 1967 |
| 4. | Mr. Brian T. Hoover | Chief Accounting Officer & Sr. VP | 1965 |
| 5. | Mr. Justin L. Mennen | Exec. VP and Chief Technology & Digital Officer | 1981 |
| 6. | Byron Purcell | VP of Investor Relations & Treasurer | NA |
| 7. | Joy Errico Seusing | Sr. VP & Chief Communications Officer | NA |
| 8. | Mr. Frank G. Vitrano | Chief Strategic Bus. Devel. Officer | 1955 |
| 9. | Ms. Jessica Kazmaier | Exec. VP & Chief HR Officer | 1978 |
| 10. | Mr. Christopher S. Hall | Sr. VP of Pharmacy Services | 1965 |
Peers
Sector: Healthcare
Industry: Pharmaceutical Retailers
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ALBHF
Alibaba Health Information Technology Limited |
0.000 0.000% | 0.6 | 36.000 | 19.011 | 0.356 | 3.633 | 1.733 | 25.724 |
|
RADLY
Raia Drogasil SA ADR |
-0.180 4.905% | 3.49 | 47.150 | 32.680 | 0.336 | 9.834 | 0.354 | 3.286 |
|
ALBBY
Alibaba Health Information Technology Limited |
+0.270 2.848% | 9.75 | 34.430 | 19.841 | 0.294 | 3.793 | 1.733 | 25.724 |
|
SHPPF
Shop Apotheke Europe N.V |
0.000 0.000% | 62.99 | 0.000 | 0.000 | 2.800 | 2.281 | 1.702 | 78.776 |
Income Statement
(Currency in USD)| Breakdown | 28-02-2023 | 28-02-2022 | 28-02-2021 | 29-02-2020 | 28-02-2019 |
|---|---|---|---|---|---|
| Income Before Tax | -756.403M | -542.258M | -120.227M | -81.612M | -589.477M |
| Minority Interest | - | - | - | - | - |
| Net Income | -749.936M | -538.478M | -100.07M | -469.219M | -422.213M |
| Selling General Administrative | 4902.087M | 4998.755M | 4657.185M | 4587.336M | 4592.375M |
| Gross Profit | 4803.94M | 5106.495M | 4704.322M | 4726.758M | 4676.352M |
| Reconciled Depreciation | 276.583M | 295.686M | 327.124M | 328.277M | 357.882M |
| Ebit | -98.147M | 72.619M | 47.137M | 139.422M | 83.977M |
| Ebitda | 178.436M | 368.305M | 374.261M | 467.699M | 441.859M |
| Depreciation And Amortization | 276.583M | 295.686M | 327.124M | 328.277M | 357.882M |
| Operating Income | -98.147M | 72.619M | 47.137M | 139.422M | 83.977M |
| Other Operating Expenses | 24190.046M | 24495.636M | 23996.103M | 21788.971M | 21555.58M |
| Interest Expense | 224.399M | 191.601M | 201.388M | 229.657M | 227.728M |
| Tax Provision | -6.467M | -3.78M | -20.157M | 387.607M | 77.477M |
| Interest Income | 224.399M | 191.601M | 201.388M | 229.657M | 227.728M |
| Net Interest Income | -224.399M | -191.601M | -201.388M | -229.657M | -227.728M |
| Income Tax Expense | -6.467M | -3.78M | -20.157M | 387.607M | 77.477M |
| Total Revenue | 24091.899M | 24568.255M | 24043.24M | 21928.393M | 21639.557M |
| Total Operating Expenses | 4902.087M | 5033.876M | 4657.185M | 4587.336M | 4592.375M |
| Cost Of Revenue | 19287.959M | 19461.76M | 19338.918M | 17201.635M | 16963.205M |
| Total Other Income Expense Net | -658.256M | -614.877M | -167.364M | -221.034M | -445.726M |
| Net Income From Continuing Ops | -749.936M | -538.478M | -100.07M | -469.219M | -666.954M |
| Net Income Applicable To Common Shares | -749.936M | -538.478M | -90.909M | -452.174M | -422.213M |
Balance Sheet
(Currency in USD)| Breakdown | 28-02-2023 | 28-02-2022 | 28-02-2021 | 29-02-2020 | 28-02-2019 |
|---|---|---|---|---|---|
| Total Assets | 7527.362M | 8529.003M | 9335.404M | 9452.369M | 7591.367M |
| Intangible Assets | 250.112M | 291.196M | 340.519M | 359.491M | 448.706M |
| Other Current Assets | 93.194M | 106.749M | 106.941M | 181.794M | 179.132M |
| Total Liab | 8169.138M | 8429.97M | 8720.25M | 8777.842M | 6404.677M |
| Total Stockholder Equity | -641.776M | 99.033M | 615.154M | 674.527M | 1186.69M |
| Other Current Liab | 724.529M | 780.632M | 642.364M | 37.063M | 727.731M |
| Common Stock | 56.629M | 55.752M | 55.143M | 54.716M | 1080.321M |
| Capital Stock | 56.629M | 55.752M | 55.143M | 54.716M | 54.016M |
| Retained Earnings | -6601.517M | -5851.581M | -5313.103M | -5222.194M | -4713.244M |
| Good Will | 507.936M | 879.136M | 1108.136M | 1108.136M | 1108.136M |
| Other Assets | 63.29M | 106.614M | 139.958M | 157.985M | 624.292M |
| Cash | 157.151M | 39.721M | 160.902M | 218.18M | 144.353M |
| Cash And Equivalents | 157.151M | 39.721M | 160.902M | 218.18M | 144.353M |
| Total Current Liabilities | 2727.875M | 2933.088M | 2602.946M | 2766.463M | 2443.135M |
| Current Deferred Revenue | - | - | - | 746.318M | 80.708M |
| Net Debt | 5662.365M | 5886.38M | 6271.35M | 6087.762M | 3350.407M |
| Short Term Debt | 508.735M | 581.195M | 523.161M | 499.001M | 16.111M |
| Short Long Term Debt | 6.332M | 5.544M | 6.409M | 8.84M | 16.111M |
| Short Long Term Debt Total | 5819.516M | 5926.101M | 6432.252M | 6305.942M | 3494.76M |
| Other Stockholder Equity | 5917.964M | 5910.299M | 5897.168M | 5890.903M | 4850.672M |
| Property Plant Equipment | 3404.977M | 3802.702M | 4144.576M | 1215.838M | 1308.514M |
| Total Current Assets | 3301.047M | 3449.355M | 3595.174M | 3700.641M | 4101.719M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | - | - | - | 7.191M |
| Net Receivables | 1149.958M | 1343.496M | 1462.441M | 1286.785M | 1788.712M |
| Long Term Debt | 2925.258M | 2732.986M | 3063.087M | 3077.268M | 3454.585M |
| Inventory | 1900.744M | 1959.389M | 1864.89M | 1921.604M | 1871.941M |
| Accounts Payable | 1494.611M | 1571.261M | 1437.421M | 1484.081M | 1618.585M |
| Accumulated Other Comprehensive Income | -14.852M | -15.437M | -24.054M | -48.898M | -31.059M |
| Non Currrent Assets Other | 50.922M | 86.543M | 132.035M | 148.327M | 215.208M |
| Non Current Assets Total | 4226.315M | 5079.648M | 5740.23M | 5751.728M | 3489.648M |
| Capital Lease Obligations | 2887.926M | 3187.571M | 3362.756M | 3219.834M | 24.064M |
| Long Term Debt Total | 2937.838M | 2747.816M | 3063.087M | 3077.268M | 3478.649M |
Cash Flow
(Currency in USD)| Breakdown | 28-02-2023 | 28-02-2022 | 28-02-2021 | 29-02-2020 | 28-02-2019 |
|---|---|---|---|---|---|
| Investments | -104.759M | -134.073M | -15.025M | -86.542M | 2.587M |
| Total Cashflows From Investing Activities | -104.759M | -134.073M | -15.025M | -149.849M | -198.552M |
| Total Cash From Financing Activities | 274.628M | -366.38M | -65.243M | -326.652M | -540.504M |
| Net Income | -749.936M | -538.478M | -100.07M | -469.219M | -666.954M |
| Change In Cash | 117.43M | -121.181M | -57.278M | 73.827M | -302.981M |
| Begin Period Cash Flow | 39.721M | 160.902M | 218.18M | 144.353M | 447.334M |
| End Period Cash Flow | 157.151M | 39.721M | 160.902M | 218.18M | 144.353M |
| Total Cash From Operating Activities | -52.439M | 379.272M | 22.99M | 487.021M | -228.665M |
| Depreciation | 276.583M | 295.686M | 327.124M | 328.277M | 357.882M |
| Other Cashflows From Investing Activities | 110.526M | 86.64M | 284.702M | 63.307M | 660.379M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | 5.158M | -97.112M | 177.263M | 15.141M | -44.645M |
| Sale Purchase Of Stock | 0M | 0M | 0.053M | - | 2.294M |
| Other Cashflows From Financing Activities | 552.569M | 319.656M | 993.241M | 604.451M | -102.428M |
| Capital Expenditures | 247.685M | 220.713M | 224.941M | 214.386M | 244.689M |
| Change In Working Capital | -100.478M | 169.122M | -38.529M | 323.235M | -433.47M |
| Other Non Cash Items | 502.152M | 446.601M | -167.905M | -97.263M | 406.124M |
| Free Cash Flow | -300.124M | 158.559M | -201.951M | 272.635M | -473.354M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Royce Micro Cap Trust | 2 years ago | 200000 |
| 2. | BlackRock Extended Mkt Composite | 2 years ago | 130695 |
| 3. | BlackRock Extended Equity Market K | 2 years ago | 114250 |
| 4. | NT Ext Equity Mkt Idx Fd - NL | 2 years ago | 47149 |
| 5. | NT Ext Equity Mkt Idx Fd - L | 2 years ago | 46190 |
| 6. | Northern Trust Extended Eq Market Idx | 2 years ago | 46190 |
| 7. | T. Rowe Price U.S. Equities Tr | 2 years ago | 38580 |
| 8. | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 2 years ago | 37796 |
| 9. | UBS FTSE RAFI Developed 1000 Index J Inc | 2 years ago | 22814 |
| 10. | SSgA U.S. Extended Market Index Class I | 2 years ago | 21541 |
| 11. | BlackRock U.S. Equity Market F | 2 years ago | 20796 |
| 12. | Bullfinch Greater Western New York | 2 years ago | 14400 |
| 13. | Extended Equity Market Fund M | 2 years ago | 13427 |
| 14. | Northern Small Cap Core K | 2 years ago | 9010 |
| 15. | FTSE RAFI U.S. 1000 Index Fund F | 2 years ago | 7637 |
| 16. | SSgA U.S. Total Market Index Strategy | 2 years ago | 6357 |
| 17. | Victory Extended Market Index | 2 years ago | 6044 |
| 18. | NT Quality SCC US Fund - L | 2 years ago | 5540 |
| 19. | NT Quality Small Cap Core | 2 years ago | 5540 |
| 20. | NT US Market Cap Idx Fd - L | 2 years ago | 4645 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Charles Schwab Investment Management Inc | 2 years ago | 4997227 |
| 2. | Vanguard Group Inc | 2 years ago | 2895724 |
| 3. | GMT Capital Corp | 2 years ago | 1482101 |
| 4. | Barclays PLC | 2 years ago | 1135998 |
| 5. | BlackRock Inc | 2 years ago | 1022842 |
| 6. | Renaissance Technologies Corp | 2 years ago | 722600 |
| 7. | Susquehanna International Group, LLP | 2 years ago | 640394 |
| 8. | Geode Capital Management, LLC | 2 years ago | 540035 |
| 9. | Silver Point Capital LP | 2 years ago | 500000 |
| 10. | State Street Corporation | 2 years ago | 325687 |
| 11. | AQR Capital Management LLC | 2 years ago | 294739 |
| 12. | Amvescap Plc. | 2 years ago | 262852 |
| 13. | Man Group PLC | 2 years ago | 252400 |
| 14. | Virtu Financial LLC | 2 years ago | 220424 |
| 15. | Royce & Associates, LP | 2 years ago | 200000 |
| 16. | Northern Trust Corp | 2 years ago | 123903 |
| 17. | Compass Rose Asset Management LP | 2 years ago | 118000 |
| 18. | DRW Securities, LLC | 2 years ago | 112200 |
| 19. | Morgan Stanley - Brokerage Accounts | 2 years ago | 108437 |
| 20. | SG Americas Securities, LLC | 2 years ago | 91751 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).